| D-0290-2025 | Class II | Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), Rx Only, 100 Unit Dose Blister Cards of 10 (10 | March 7, 2025 |
| D-0291-2025 | Class II | Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), Rx Only, 100 Unit Dose Blister Cards of 10 (1 | March 7, 2025 |
| D-0132-2025 | Class II | Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 100 Tablets per carton (10 unit dose blister | November 19, 2024 |
| D-0131-2025 | Class II | Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), 100 Tablets per carton (10 unit dose blister ca | November 19, 2024 |
| D-0135-2025 | Class II | Levothyroxine Sodium Tablets, USP, 150 mcg (0.150 mg), 100 Tablets per carton (10 unit dose blister | November 19, 2024 |
| D-0133-2025 | Class II | Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 100 Tablets per carton (10 unit dose blister | November 19, 2024 |
| D-0134-2025 | Class II | Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg), 100 Tablets per carton (10 unit dose blister | November 19, 2024 |
| D-0136-2025 | Class II | Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), 100 Tablets per carton (10 unit dose blister | November 19, 2024 |
| D-0601-2021 | Class III | Thiamine HCl Injection, USP 200 mg/2 mL (100mg/mL), 2 mL vials, packaged in 25 (2 mL multi-dose vial | May 3, 2021 |
| D-1575-2020 | Class I | Amiodarone Hydrochloride Injection, USP, 450 mg/9 mL (50 mg/mL), 9 mL Single-Dose Vial (NDC 67457-15 | August 17, 2020 |
| D-1576-2020 | Class I | Tranexamic Acid Injection, USP, 1000 mg/10 mL (100 mg/mL), 10 mL Single-Dose Vial (NDC 67457-197-00) | August 17, 2020 |
| D-1484-2020 | Class I | Daptomycin for Injection, 500 mg/vial, Single-Dose Vial, Rx only, Sterile, Manufactured for: Mylan I | July 7, 2020 |
| D-1271-2020 | Class II | Aloprim (allopurinol sodium) for Injection, 500 mg Single-Dose Vial, Rx only, Manufactured for: Myla | May 5, 2020 |
| D-1059-2019 | Class I | Levoleucovorin Injection, 250 mg/25 mL, (10 mg/mL), 25 mL Single-Use Vial, Rx only, Manufactured for | February 1, 2019 |
| D-1329-2015 | Class I | Cytarabine Injection 100 mg/5 mL (20 mg/mL), 5 mL Single-Dose Vial (NDC 0069-0152-01), packaged in 1 | April 23, 2015 |
| D-1333-2015 | Class I | Gemcitabine for Injection, USP, 2 g*/vial, Lyophilized powder in a Single-Use Vial, Rx only, Manufac | March 23, 2015 |
| D-1332-2015 | Class I | Gemcitabine for Injection, USP, 200 mg*/vial, Lyophilized powder in a Single-Use Vial, Rx only, labe | March 23, 2015 |
| D-1334-2015 | Class I | Gemcitabine for Injection, USP, 1 g*/vial, Lyophilized powder in a Single-Use Vial, Rx only, Manufac | March 23, 2015 |
| D-1331-2015 | Class I | CARBOplatin Injection 450 mg/45 mL (10 mg/mL), 45 mL packaged in a 100 mL Multi-Dose Vial, Rx only, | March 18, 2015 |
| D-1328-2015 | Class I | Methotrexate Injection, USP 50 mg/2 mL (25 mg/mL), 2 mL Single-dose Vial, packaged in 5 x 2 mL vials | March 18, 2015 |